Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

NCT05901545 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Panitumumab
OTHER: Indium In 111 Panitumumab
PROCEDURE: Single Photon Emission Computed Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Surgical Procedure
OTHER: Imaging agent
PROCEDURE: Intraoperative Imaging
PROCEDURE: Near Infrared Imaging
PROCEDURE: Electrocardiography
PROCEDURE: Biospecimen Collection

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]